Skip to main content

Table 3 Patient characteristics at baseline

From: Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry

BRE-4-MED participants with baseline information
Female sex, n (%)30 (96.8)
Age, mean (std), years57.1 (± 13.5)
Time since diagnosis of MBC, median (IQR), months21.0 (7–45)
Care given by family member*, n (%)6 (21.4)
Returned questionnaires of family members*, n (%)15 (50.0)
Number of metastasis location, n (%)
 19 (29.0)
 210 (32.3)
 35 (16.1)
 45 (16.1)
 51 (3.2)
 61 (3.2)
Kind of administered medication, n (%)
 No information on medication specified1 (3.2)
 Oral only2 (6.5)
 Oral + subcutaneous1 (3.2)
 IV only14 (45.2)
 IV + oral11 (35.5)
 IV + oral and subcutaneous2 (6.5)
  1. *Analyses were restricted to patients without missing values